Search research articles
Contact Us
Filters
Showing results (221-230 of 361) with videos related to
Page
of 37
Sort By:
Journal of Clinical and Translational Science
|
December 2, 2024
Using the Translational Science Benefits Model to assess the impact of the Penn Implementation Science Center in Cancer Control
Robert Schnoll, Justin E Bekelman, Daniel Blumenthal, et al.
Biorxiv : the Preprint Server for Biology
|
January 3, 2024
Saturation genome editing-based functional evaluation and clinical classification of BRCA2 single nucleotide variants
Huaizhi Huang, Chunling Hu, Jie Na, et al.
Medrxiv : the Preprint Server for Health Sciences
|
August 20, 2025
Pathogenic germline variants in a racially diverse real-world cohort of prostate cancer patients
Taylor B Crawford, Maliha Tayeb, Emanuel Barrett, et al.
Cancer
|
December 10, 2021
A randomized study of genetic education versus usual care in tumor profiling for advanced cancer in the ECOG-ACRIN Cancer Research Group (EAQ152)
Angela R Bradbury, Ju-Whei Lee, Jill Bennett Gaieski, et al.
Current Oncology (Toronto, Ont.)
|
May 26, 2026
Cancer During Pregnancy: Navigating Clinical and Research Challenges
Mackenzie K Callaway, Lizelle Comfort, Dhivyaa Anandan, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
June 2, 2026
Pathogenic Germline Variants in a Racially Diverse Real-World Cohort of Patients With Prostate Cancer
Taylor B Crawford, Maliha Tayeb, Emanuel Barrett, et al.
The Lancet. Oncology
|
August 11, 2020
Olaparib and durvalumab in patients with germline BRCA-mutated metastatic breast cancer (MEDIOLA): an open-label, multicentre, phase 1/2, basket study
Susan M Domchek, Sophie Postel-Vinay, Seock-Ah Im, et al.
JCO Precision Oncology
|
November 4, 2022
Development and Validation of a Breast Cancer Polygenic Risk Score on the Basis of Genetic Ancestry Composition
Elisha Hughes, Susanne Wagner, Dmitry Pruss, et al.
JAMA
|
September 3, 2010
Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality
Susan M Domchek, Tara M Friebel, Christian F Singer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 22, 2018
Multicenter Phase II Study of Lurbinectedin in BRCA-Mutated and Unselected Metastatic Advanced Breast Cancer and Biomarker Assessment Substudy
Cristina Cruz, Alba Llop-Guevara, Judy E Garber, et al.
Page
of 37
Search research articles
Search
Showing results (221-230 of 361) with videos related to
Sort By:
Page
of 37
Journal of Clinical and Translational Science
|
December 2, 2024
Using the Translational Science Benefits Model to assess the impact of the Penn Implementation Science Center in Cancer Control
Robert Schnoll, Justin E Bekelman, Daniel Blumenthal, et al.
Biorxiv : the Preprint Server for Biology
|
January 3, 2024
Saturation genome editing-based functional evaluation and clinical classification of BRCA2 single nucleotide variants
Huaizhi Huang, Chunling Hu, Jie Na, et al.
Medrxiv : the Preprint Server for Health Sciences
|
August 20, 2025
Pathogenic germline variants in a racially diverse real-world cohort of prostate cancer patients
Taylor B Crawford, Maliha Tayeb, Emanuel Barrett, et al.
Cancer
|
December 10, 2021
A randomized study of genetic education versus usual care in tumor profiling for advanced cancer in the ECOG-ACRIN Cancer Research Group (EAQ152)
Angela R Bradbury, Ju-Whei Lee, Jill Bennett Gaieski, et al.
Current Oncology (Toronto, Ont.)
|
May 26, 2026
Cancer During Pregnancy: Navigating Clinical and Research Challenges
Mackenzie K Callaway, Lizelle Comfort, Dhivyaa Anandan, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
June 2, 2026
Pathogenic Germline Variants in a Racially Diverse Real-World Cohort of Patients With Prostate Cancer
Taylor B Crawford, Maliha Tayeb, Emanuel Barrett, et al.
The Lancet. Oncology
|
August 11, 2020
Olaparib and durvalumab in patients with germline BRCA-mutated metastatic breast cancer (MEDIOLA): an open-label, multicentre, phase 1/2, basket study
Susan M Domchek, Sophie Postel-Vinay, Seock-Ah Im, et al.
JCO Precision Oncology
|
November 4, 2022
Development and Validation of a Breast Cancer Polygenic Risk Score on the Basis of Genetic Ancestry Composition
Elisha Hughes, Susanne Wagner, Dmitry Pruss, et al.
JAMA
|
September 3, 2010
Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality
Susan M Domchek, Tara M Friebel, Christian F Singer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 22, 2018
Multicenter Phase II Study of Lurbinectedin in BRCA-Mutated and Unselected Metastatic Advanced Breast Cancer and Biomarker Assessment Substudy
Cristina Cruz, Alba Llop-Guevara, Judy E Garber, et al.
Page
of 37